Effectiveness of a Three-Week Inpatient Pulmonary Rehabilitation Program for Patients after COVID-19: A Prospective Observational Study.
COVID-19
course of recovery
inpatient rehabilitation
pulmonary rehabilitation
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
26 08 2021
26 08 2021
Historique:
received:
23
07
2021
revised:
19
08
2021
accepted:
21
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
15
9
2021
Statut:
epublish
Résumé
For COVID-19 patients who remain symptomatic after the acute phase, pulmonary rehabilitation (PR) is recommended. However, only a few studies have investigated the effectiveness of PR, especially considering the duration between the acute phase of COVID-19 and the onset of rehabilitation, as well as the initial severity. This prospective observational study evaluated the efficacy of PR in patients after COVID-19. A total of 120 still-symptomatic patients referred for PR after overcoming acute COVID-19 were asked to participate, of whom 108 (mean age 55.6 ± 10.1 years, 45.4% female) consented. The patients were assigned to three groups according to the time of referral and initial disease severity (severe acute; severe after interval; mild after interval). The primary outcome was dyspnea. Secondary outcomes included other respiratory disease symptoms, physical capacity, lung function, fatigue, quality of life (QoL), depression, and anxiety. Furthermore, patients rated the overall effectiveness of PR and their subjective change in health status. At the end of PR, we detected improvements with large effect sizes in exertional dyspnea, physical capacity, QoL, fatigue, and depression in the overall group. Other parameters changed with small to medium effect sizes. PR was effective after acute COVID-19 in all three groups analyzed.
Identifiants
pubmed: 34501596
pii: ijerph18179001
doi: 10.3390/ijerph18179001
pmc: PMC8430843
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
M.C.H., M.L., S.M., G.S., K.J. and K.S. are employees of the Bad Reichenhall Clinic. D.N. and M.S. declare no conflict of interest.
Références
Eur Respir J. 2020 Aug 13;:
pubmed: 32817258
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
ERJ Open Res. 2021 May 31;7(2):
pubmed: 34095290
Respir Med. 2011 Jul;105(7):959-71
pubmed: 21356587
Rev Neurol. 2021 Jun 1;72(11):384-396
pubmed: 34042167
Ann Intern Med. 2021 May;174(5):723-725
pubmed: 33284676
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Clin Microbiol Infect. 2021 Jun;27(6):892-896
pubmed: 33662544
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Cancer. 1999 Mar 1;85(5):1186-96
pubmed: 10091805
Eur J Phys Rehabil Med. 2021 Jun;57(3):443-450
pubmed: 33393278
ESC Heart Fail. 2021 Jun;8(3):2232-2239
pubmed: 33773099
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Am J Phys Med Rehabil. 2020 Oct;99(10):865-869
pubmed: 32732746
Respiration. 2015;90(4):287-92
pubmed: 26340440
Pneumologie. 2020 Aug;74(8):496-504
pubmed: 32583378
Eur J Phys Rehabil Med. 2021 Apr;57(2):181-188
pubmed: 33599442
Respir Physiol Neurobiol. 2021 Jun;288:103644
pubmed: 33647535
J Man Manip Ther. 2009;17(3):163-70
pubmed: 20046623
Eur J Clin Microbiol Infect Dis. 2021 Apr 23;:
pubmed: 33893570
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Multidiscip Respir Med. 2020 Oct 13;15(1):713
pubmed: 33117535
Eur J Phys Rehabil Med. 2021 Apr;57(2):208-215
pubmed: 33541042
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
J Affect Disord. 2018 May;232:268-275
pubmed: 29499510
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Am J Crit Care. 1998 May;7(3):200-4
pubmed: 9579246
Int J Environ Res Public Health. 2021 Feb 19;18(4):
pubmed: 33669714
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Eur Respir J. 2011 Apr;37(4):784-90
pubmed: 20693247
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Am Heart J. 2012 Aug;164(2):229-35
pubmed: 22877809
Int J Chron Obstruct Pulmon Dis. 2021 Jul 02;16:1977-1988
pubmed: 34239299
J Int Med Res. 2020 Aug;48(8):300060520948382
pubmed: 32840156
NPJ Prim Care Respir Med. 2016 Sep 01;26:16041
pubmed: 27597571
Dtsch Arztebl Int. 2021 Jan 22;118(3):23-30
pubmed: 33759752
Monaldi Arch Chest Dis. 2020 Jun 23;90(2):
pubmed: 32573175
Multidiscip Respir Med. 2021 Jan 25;16(1):732
pubmed: 33623700
Eur Respir J. 2018 Jan 25;51(1):
pubmed: 29371382
Respir Med. 2021 May;181:106391
pubmed: 33865161
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Lancet Respir Med. 2021 Jul;9(7):747-754
pubmed: 33964245
Am J Infect Control. 2021 Feb;49(2):238-246
pubmed: 32659414
Eur Respir J. 2008 Sep;32(3):637-43
pubmed: 18550610
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7
pubmed: 9817683
Pneumologie. 2015 Mar;69(3):147-64
pubmed: 25750095
Respir Med. 2021 Jan;176:106272
pubmed: 33302142
Multidiscip Respir Med. 2010 Jun 30;5(3):202-10
pubmed: 22958431
Arch Rehabil Res Clin Transl. 2021 Jun;3(2):100108
pubmed: 33558860
Int J Environ Res Public Health. 2021 Mar 07;18(5):
pubmed: 33800094
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
J Pain Symptom Manage. 2003 May;25(5):449-58
pubmed: 12727043
Eur Respir J. 2013 Aug;42(2):444-53
pubmed: 23100507
Respir Care. 2015 Jan;60(1):88-95
pubmed: 25336531
Eur J Pain. 2004 Aug;8(4):283-91
pubmed: 15207508
Eur J Phys Rehabil Med. 2021 Jun;57(3):481-484
pubmed: 33861041
Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198
pubmed: 33448756
Intern Emerg Med. 2021 May 27;:
pubmed: 34046852
Respir Physiol Neurobiol. 2021 May;287:103639
pubmed: 33588090